These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14742205)

  • 1. New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity.
    Beyer D; Kroll HP; Endermann R; Schiffer G; Siegel S; Bauser M; Pohlmann J; Brands M; Ziegelbauer K; Haebich D; Eymann C; Brötz-Oesterhelt H
    Antimicrob Agents Chemother; 2004 Feb; 48(2):525-32. PubMed ID: 14742205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.
    Mills SD; Eakin AE; Buurman ET; Newman JV; Gao N; Huynh H; Johnson KD; Lahiri S; Shapiro AB; Walkup GK; Yang W; Stokes SS
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1088-96. PubMed ID: 21189350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability.
    Abibi A; Ferguson AD; Fleming PR; Gao N; Hajec LI; Hu J; Laganas VA; McKinney DC; McLeod SM; Prince DB; Shapiro AB; Buurman ET
    J Biol Chem; 2014 Aug; 289(31):21651-62. PubMed ID: 24936059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Methionyl-tRNA Synthetase Inhibitors as Antibiotics for Gram-Positive Bacterial Infections.
    Faghih O; Zhang Z; Ranade RM; Gillespie JR; Creason SA; Huang W; Shibata S; Barros-Álvarez X; Verlinde CLMJ; Hol WGJ; Fan E; Buckner FS
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods to assay inhibitors of tRNA synthetase activity.
    Beyer D; Kroll HP; Brötz-Oesterhelt H
    Methods Mol Med; 2008; 142():53-61. PubMed ID: 18437305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of the first class of potent bacterial acetyl-CoA carboxylase inhibitors with antibacterial activity.
    Freiberg C; Brunner NA; Schiffer G; Lampe T; Pohlmann J; Brands M; Raabe M; Häbich D; Ziegelbauer K
    J Biol Chem; 2004 Jun; 279(25):26066-73. PubMed ID: 15066985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.
    Lv PC; Zhu HL
    Curr Med Chem; 2012; 19(21):3550-63. PubMed ID: 22680640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel and potent class of FabI-directed antibacterial agents.
    Payne DJ; Miller WH; Berry V; Brosky J; Burgess WJ; Chen E; DeWolf WE; Fosberry AP; Greenwood R; Head MS; Heerding DA; Janson CA; Jaworski DD; Keller PM; Manley PJ; Moore TD; Newlander KA; Pearson S; Polizzi BJ; Qiu X; Rittenhouse SF; Slater-Radosti C; Salyers KL; Seefeld MA; Smyth MG; Takata DT; Uzinskas IN; Vaidya K; Wallis NG; Winram SB; Yuan CC; Huffman WF
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3118-24. PubMed ID: 12234833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallesia integrifolia (Spreng.) Harms: In vitro and in vivo antibacterial activities and mode of action.
    Arunachalam K; Ascêncio SD; Soares IM; Souza Aguiar RW; da Silva LI; de Oliveira RG; Balogun SO; de Oliveira Martins DT
    J Ethnopharmacol; 2016 May; 184():128-37. PubMed ID: 26945980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
    Ueda Y; Sunagawa M
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
    Lepak AJ; Seiler P; Surivet JP; Ritz D; Kohl C; Andes DR
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antibacterial class.
    Dandliker PJ; Pratt SD; Nilius AM; Black-Schaefer C; Ruan X; Towne DL; Clark RF; Englund EE; Wagner R; Weitzberg M; Chovan LE; Hickman RK; Daly MM; Kakavas S; Zhong P; Cao Z; David CA; Xuei X; Lerner CG; Soni NB; Bui M; Shen LL; Cai Y; Merta PJ; Saiki AY; Beutel BA
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3831-9. PubMed ID: 14638491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel DNA gyrase inhibitors: microbiological characterisation of pyrrolamides.
    Uria-Nickelsen M; Blodgett A; Kamp H; Eakin A; Sherer B; Green O
    Int J Antimicrob Agents; 2013 Jan; 41(1):28-35. PubMed ID: 23142086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
    Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
    J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New aminoacyl-tRNA synthetase inhibitors as antibacterial agents.
    Pohlmann J; Brötz-Oesterhelt H
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):261-72. PubMed ID: 15578968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants.
    Freiberg C; Fischer HP; Brunner NA
    Antimicrob Agents Chemother; 2005 Feb; 49(2):749-59. PubMed ID: 15673760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase.
    Jarvest RL; Erskine SG; Forrest AK; Fosberry AP; Hibbs MJ; Jones JJ; O'Hanlon PJ; Sheppard RJ; Worby A
    Bioorg Med Chem Lett; 2005 May; 15(9):2305-9. PubMed ID: 15837314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.